196 related articles for article (PubMed ID: 32256368)
1. Clinical Efficacy Evaluation of 1-Year Subcutaneous Immunotherapy for
Shi HY; Pan C; Ma TT; Chen YL; Yan WJ; Liu JG; Cao MD; Huang HD; Wang DY; Wang XY; Wei JF
Front Pharmacol; 2020; 11():305. PubMed ID: 32256368
[TBL] [Abstract][Full Text] [Related]
2. Prediction of clinical efficacy of subcutaneous immunotherapy for Artemisia sieversiana pollen allergic rhinitis by serum metabolomics.
Yu RL; Pan C; Ma TT; Wang XY; Shi HY; Zhuang Y; Yan WJ; Liu JG; Cao MD; Sun JL; Wang DY; Yin JS; Wei JF; Wang XY
J Formos Med Assoc; 2022 Dec; 121(12):2465-2480. PubMed ID: 35623930
[TBL] [Abstract][Full Text] [Related]
3. Prediction of sublingual immunotherapy efficacy in allergic rhinitis by serum metabolomics analysis.
Xie S; Jiang S; Zhang H; Wang F; Liu Y; She Y; Jing Q; Gao K; Fan R; Xie S; Xie Z; Jiang W
Int Immunopharmacol; 2021 Jan; 90():107211. PubMed ID: 33271394
[TBL] [Abstract][Full Text] [Related]
4. Metabolomics analysis of three Artemisia species in the Tibet autonomous region of China.
Liu X; Wang J; Huang E; Li B; Zhang S; Wang W; Guo Z; Wu K; Zhang Y; Zhao B; Lu H
BMC Plant Biol; 2022 Mar; 22(1):118. PubMed ID: 35291945
[TBL] [Abstract][Full Text] [Related]
5. Relationship between serum inhibitory activity for IgE and efficacy of Artemisia pollen subcutaneous immunotherapy for allergic rhinitis: a preliminary self-controlled study.
Wang W; Yin J; Wang X; Ma T; Lan T; Song Q; Guo Y
Allergy Asthma Clin Immunol; 2020; 16():18. PubMed ID: 32158477
[TBL] [Abstract][Full Text] [Related]
6. Artemisia sieversiana pollen allergy and immunotherapy in mice.
Zhang Q; Xi G; Yin J
Am J Transl Res; 2021; 13(12):13654-13664. PubMed ID: 35035704
[TBL] [Abstract][Full Text] [Related]
7. [Clinical observation on specific immunotherapy of allergic rhinitis with artemisia pollen].
Liu AZ; Wang XY; Yin JS; Yu RL; Ma TT
Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2018 Oct; 32(20):1580-1583. PubMed ID: 30400711
[No Abstract] [Full Text] [Related]
8. [The clinical study about the serum total and specific IgE levels in Artemisia pollen-induced allergic rhinitis patients].
Wang M; Xing Z; Feng W; He X; Ma Y
Lin Chuang Er Bi Yan Hou Ke Za Zhi; 2006 Oct; 20(20):925-7. PubMed ID: 17225520
[TBL] [Abstract][Full Text] [Related]
9. Suppression of seasonal increase in serum interleukin-5 is linked to the clinical efficacy of immunotherapy for seasonal allergic rhinitis.
Hayashi M; Ohashi Y; Tanaka A; Kakinoki Y; Nakai Y
Acta Otolaryngol Suppl; 1998; 538():133-42. PubMed ID: 9879413
[TBL] [Abstract][Full Text] [Related]
10. Association of serum specific IgE levels with asthma in autumn pollen-induced allergic rhinitis: A retrospective analysis.
Cui L; Yin J
J Asthma; 2019 May; 56(5):505-511. PubMed ID: 29667465
[TBL] [Abstract][Full Text] [Related]
11. Subcutaneous immunotherapy for allergic rhinitis: an evidence based review of the recent literature with recommendations.
Purkey MT; Smith TL; Ferguson BJ; Luong A; Reisacher WR; Pillsbury HC; Toskala E
Int Forum Allergy Rhinol; 2013 Jul; 3(7):519-31. PubMed ID: 23315962
[TBL] [Abstract][Full Text] [Related]
12. Specific immunotherapy in local allergic rhinitis: A randomized, double-blind placebo-controlled trial with Phleum pratense subcutaneous allergen immunotherapy.
Rondón C; Blanca-López N; Campo P; Mayorga C; Jurado-Escobar R; Torres MJ; Canto G; Blanca M
Allergy; 2018 Apr; 73(4):905-915. PubMed ID: 29168570
[TBL] [Abstract][Full Text] [Related]
13. Serum levels of specific IgE, soluble interleukin-2 receptor, and soluble intercellular adhesion molecule-1 in seasonal allergic rhinitis.
Ohashi Y; Nakai Y; Tanaka A; Kakinoki Y; Ohno Y; Masamoto T; Sakamoto H; Kato A; Washio Y; Hayashi M
Ann Allergy Asthma Immunol; 1997 Sep; 79(3):213-20. PubMed ID: 9305226
[TBL] [Abstract][Full Text] [Related]
14. Antigen-specific immunotherapy against allergic rhinitis: the state of the art.
Fujimura T; Okamoto Y
Allergol Int; 2010 Mar; 59(1):21-31. PubMed ID: 20093851
[TBL] [Abstract][Full Text] [Related]
15. Short-term preseasonal birch pollen allergoid immunotherapy influences symptoms, specific nasal provocation and cytokine levels in nasal secretions, but not peripheral T-cell responses, in patients with allergic rhinitis.
Klimek L; Dormann D; Jarman ER; Cromwell O; Riechelmann H; Reske-Kunz AB
Clin Exp Allergy; 1999 Oct; 29(10):1326-35. PubMed ID: 10520053
[TBL] [Abstract][Full Text] [Related]
16. Pharmacoeconomics of allergen immunotherapy compared with symptomatic drug treatment in patients with allergic rhinitis and asthma.
Ariano R; Berto P; Tracci D; Incorvaia C; Frati F
Allergy Asthma Proc; 2006; 27(2):159-63. PubMed ID: 16724637
[TBL] [Abstract][Full Text] [Related]
17. Efficacy of pollen immunotherapy in seasonal allergic rhinitis.
Can D; Tanaç R; Demir E; Gülen F; Veral A
Pediatr Int; 2007 Feb; 49(1):64-9. PubMed ID: 17250508
[TBL] [Abstract][Full Text] [Related]
18. Cry j 1-induced synthesis of interleukin-5 and interferon-gamma by peripheral blood mononuclear cells of patients with seasonal allergic rhinitis due to Japanese cedar pollens.
Nakai Y; Ohashi Y; Tanaka A; Kakinoki Y; Washio Y; Masamoto T; Yamada K; Nakai Y; Ohmoto Y
Acta Otolaryngol Suppl; 1998; 538():143-51. PubMed ID: 9879414
[TBL] [Abstract][Full Text] [Related]
19. Artemisia allergy research in China.
Tang R; Sun JL; Yin J; Li Z
Biomed Res Int; 2015; 2015():179426. PubMed ID: 26000282
[TBL] [Abstract][Full Text] [Related]
20. A metabolomics research based on UHPLC-ESI-Q-TOF-MS coupled with metabolic pathway analysis: Treatment effects of stir-frying Xanthii Fructus on allergic rhinitis in mice model.
Zhuang Y; Qin K; Yu B; Liu X; Cai B; Cai H
Biomed Chromatogr; 2018 Dec; 32(12):e4352. PubMed ID: 30062682
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
